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The type-specific somatic antigen of Phase II Shigella  sonnei  is a  lipomuco- 
protein complex which has the ability to inhibit in vitro all the T  coil-dysentery 
phages to which this microorganism is known to be susceptible (1). Because of 
this it has been suggested that the antigen, which is present on the cell surface 
of the Phase II bacillus, serves as the receptor for the T  viruses which attack 
this particular dysentery bacillus  (2). 
In order that a phage may combine specifically with a  susceptible bacterial 
cell it is essential that sufficient binding forces be available between the two 
structures.  Since  the geometric pattern  of these  structures  is determined  by 
the  chemical nature of the substances distributed  on  the surface of both  the 
virus and the cell, it is reasonable to assume that combination can occur only 
if these  active groups possess a  precise spatial  relationship.  If the  chemical 
nature  of the  cell  surface were  to  undergo  change,  the  relationship  of these 
forces would be disturbed  and  the virus might no longer be capable of com- 
bining with the cell in question. 
If this hypothesis has any basis in fact, it should be possible to demonstrate 
differences,  both  chemical  and  immunological,  between  the  antigen of  the 
Phase II organism and  that of a  phage-resistant variant.  Such a  variant has 
been  isolated;  it  was  obtained  by plating  a  large  population  of susceptible 
Phase II bacilli with a mixture of T3, T4, and T~ phages and selecting a resistant 
colony. This variant, designated as 11/3, 4, 7 because of its resistance to these 
three phages, is the subject of the study which follows. It will be seen that this 
bacillus,  like the  cell from which  it was derived,  also  elaborates a  lipomuco- 
protein, but that this latter differs from that of the parent in serological speci- 
ficity, antiviral properties, and chemical make-up. 
Materials and Methods 
Strains of Microorganisms.--The Phase II bacillus used was obtained some years ago from 
the United States Army Medical School collection. It has been kept in a frozen state (- 78°C.) 
in 50 per cent horse serum. The phage-resistant variant, 11/3, 4, 7, was isolated as described 
in the experimental procedure. 
Bozteviophages and  Pkage Assays.--The  bacteriophages employed were obtained  from 
Dr. Mark Adams of New York University. Freshly prepared stocks of the various viruses 
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were used throughout  this work and were obtained in the usual manner by passage on F.s- 
cher~hia coli B. Phage assays were conducted according to the technique of Hershey (3). 
Med/a.--Both Difco nutrient broth and  1 per cent neopeptone-meat extract media were 
used.  Solid media were prepared  by the addition of 1.5 per cent Difco agar.  The somatic 
antigen of the variant II/3, 4, 7 was obtained from organisms grown at pH 7.0 in a medium 
containing 1 per cent casamino acids and dialyzed meat extract (4). 
Inhibigon  Tezts.--Viral inhibition tests were conducted as previously described (2). Plat- 
ings of the T7 virus were made on neopeptone-meat infusion agar because this medium con- 
tains cofactors of unknown nature which give a somewhat larger number of plaques than when 
platings are made on nutrient broth agar. 
Antisera.--Antibacterial  sera  were obtained  from  rabbits  which had  received multiple 
intravenous injections of living Phase II bacilli, or the variant II/3, 4, 7. In order to mini- 
mize the toxic effects of the microorganisms,  it was  advantageous  to  administer  the  first 
injection intradermally; 0.2  ml. of living bacilli containing 2  X  10  '0 micoorganis~as  per ml. 
was therefore given as the first dose.  5 days later, 0.1 ml. of 1 X  l0  s bacilli per ml. was in- 
jected intravenously;  the injections were made on alternate days thereafter,  and  the dose 
was doubled each time, until 1.6 ml. had been given. Two series  of injections, with a  rest 
period of 1 week between courses,  were administered. Bleedings were made 8 days after the 
last injection. 
Antisera to the two somatic antigens, that from the Phase II bacillus, and from the vari. 
ant II/3, 4,  7, were obtained by injecting two separate groups of rabbits with sterile saline 
solutions of these substances. Here again it was desirable to administer as the initial dose 0.2 
ml. of the antigen solution containing 5 mg. per ml., intradermally. The first intravenous dose, 
containing 0.05 rag.  of antigen, was given 5 days later. After administering a  total of some 
2.0 mg. of antigen intravenously, the animals were bled. The anti-sera thus obtained, agglu- 
tinated, in high dilution, the homologous microorganisms, and  gave potent precipitin reac- 
tions with the respective antigens. 
Somatic Antigens.--The  somatic antigen of Phase II Sh. sonnei was prepared as outlined 
in the previous communication (1). The preparation of the antigen of the variant, II/3, 4, 7, 
will be described in the experimental procedure which follows. 
Agglutination  and Prexipitin  Tests.--Agglutination  tests were conducted in the ordinary 
manner; it was necessary to use young living cultures of II/3, 4, 7 because the organism has 
a tendency to agglutinate spontaneously if the cultures are more than 4 to 5 hours old. The 
vaccines contained about 2.5  X  l0  s organisms per ml. A broth suspension of the bacteria 
was used and the antisera were also diluted in nutrient broth. The tubes were read after in- 
cubation at 37°C. for 2 hours. In all instances control experiments utilizing similar dilutions 
of the corresponding normal sera of the animals, were included in the tests. Any rabbit whose 
normal  serum spontaneously  agglutinated  the phage-resistant  variant  II/3, 4,  7,  was  dis- 
carded before the immunization schedule was begun. 
Analytical  Methods.--Nitrogen  determinations were performed by the procedure of Koch 
and McMeekin (5), phosphorus by the method of Allen (6), and glucosamine by the technique 
of SCrensen  (7).  Quantitative turbidimetric serological  assays were performed as described 
by Libby (8). Reducing sugars were determined by the method of Shaffer  and Somogyi (9). 
EXPERIMENTAL 
Isolation  of the  Phage-Resistant  Variant  11/3,  4,  7.--Phase  II  Sh.  sonnei  is 
susceptible  to bacteriophages  T2, T6,  T3,  T4,  and  TT; it is resistant  to T1  and 
Ts.  In  order  to  procure  a  variant  organism  resistant  to  T3,  T4,  and  TT,  the 
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several resistant colonies which  appeared on  the plate were picked and freed 
of virus by repeated streaking and  selection. 
Fresh stocks of T3, T4, and T7 were prepared, and a mixture of the three phages made so 
that the final concentration  was 1 X  107 particles of T3, 7 X  109 particles of T4, and 1 )<  105 
particles of T7 per ml. It is desirable to choose these lower concentrations  of  the T3 and T7 
phages in order to eliminate lysis of any II/3, 4, 7 variants in  the Phase II cultures by host- 
range mutants. In freshly prepared stocks of T3 and T7 there is approximately one host-range 
mutant virus particle in every 105 particles of T~, and one in every 104  particles of 2"7. T4 
contains no host-range mutants which attack II/3, 4, 7 and can  therefore  be used in higher 
concentrations. 
To 0.9 ml. of a 3 1/2 hour culture of the Phase II organism containing 1 ;<  109 bacteria 
per ml. was added 0.1 ml. of the mixture of T3, T4, and T7 phages. After a few minutes, 0.1 
ml. was spread on a neopeptone-agar plate. After 24 hours  incubation,  some 32 colonies of 
the resistant variant had grown out. This represents approximately 1 phage-resistant variant 
in every 3 X  106 cells. Several of these resistant colonies were picked and freed of phage by 
emulsifying  in sterile broth, streaking,  and again  picking a  fresh  colony. The process was 
repeated three times. 
The  phage-resistant mutant  II/3,  4,  7  forms  two  types  of  colonies which 
have been termed large and small. They cannot be distinguished readily when 
plated on Difco nutrient  broth-agar,  or on  casamino acid-meat extract agar, 
but on neopeptone  (1 per cent)-meat infusion  agar they are readily recogniz- 
able.  On  this  medium,  the parent  Phase  II bacillus forms  smooth  glistening 
colonies 2 to 3 mm. in diameter with slightly irregular borders. They show only 
very slight stippling. The small colonies of II/3, 4, 7 on this  same medium  are 
1.5  to 2.5 mm. in diameter, have slightly crenated edges, are raised, and show 
moderate roughening or stippling of the surface. The large colonies of the vari- 
ant organism are from 2.5 to 3.5 ram. in diameter. They are flatter, not as shiny, 
and are considerably rougher than the small variant colonies. These differences 
are revealed to some extent in the accompanying photographs (Fig.  1). 
The large and  small colonies of the  II/3,  4,  7 variant  are serologically in- 
distinguishable.  Organisms  from  small  colonies appear  to  undergo  mutation 
to  yield bacilli which  form  large  colonies, but  the degree  of mutation  is not 
great,  and  probably does not  occur  with  a  frequency greater  than  1  in  104. 
Organisms  which  form  the  large  colonies do  not  back-mutate  to  the  small- 
colony producer. 
Extensive studies were made which establish the serological identity of these 
two  organisms  but  no  protocols will be  given  here.  The  sera  of rabbits  im- 
munized with II/3, 4, 7 (small) are completely exhausted of agglutinating anti- 
bodies when  absorbed with II/3, 4,  7  (large).  Furthermore,  the agglutinating 
antibodies are completely removed when  such  sera are absorbed with the so- 
matic antigen prepared  either from  small or large colony-forming organisms. 
In the work which is about to be described, the small colony-forming variant 
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FIG.  1.  Colony morphology of Phase II Sh. sonnei  and the phage-resistant variants II/3, 
4, 7.  (a)  Phase II Sh. sonnei;  (b) 11/3, 4, 7 (small); (c)  11/3, 4, 7  (large). All X  5. 
Cultivation  of  [I/3,  4,  7.--Mass  cultures  of  the  phage-resistant  variant, 
II/3,  4,  7,  were  obtained  as  follows:-- 
Fifteen liters of  1 per cent casamino acid  medium containing the dialyzed extract  of  1.5 
lb.  of ground beef heart  (4),  7.5 gm. of glucose, and 0.75 gin. of MgSO4 were  seeded with a 
culture of the variant 11/3, 4, 7. After incubation for 12 hours the culture contained approxi- 
mately 1  X  l0  s bacilli per ml. At this point 300 ml. of a  sterile solution of 50 per cent glu- 
cose was added, and sterile air was bubbled through the 5 gallon pyrex glass container. After 
some 60 to 90 minutes, rapid growth ensued. The pH of the medium was maintained at 7.2 + 
0.02 by means of an electronic device  1 which automatically added a  sterile solution of molar 
Na2CO~.  After some 5  hours,  the bacterial  population  had  reached  approximately 3  X  109 
organisms per  ml. and  growth had  stopped.  The culture was killed  by the addition  of a  50 
per cent alcoholic solution of phenol so that  the final concentration was 0.5  per cent.  After 
standing at  5°C.  for  15  hours,  the organisms were  separated  in  a  Sharpies  centrifuge and 
dried from the frozen state. Each batch of the variant so prepared was tested for the presence 
of Phase II  bacilli,  which might have arisen by back-mutation, in  the following manner:- 
To 0.9 ml. of culture was added 0.1  nal.  of T4 phage containing 2  X  l0  s particles per ml. 
After standing for 5 minutes at 37°C, 0.1 ml. of this mixture was added to  0.9 ml. of a  dilu- 
tion of T4 antiserum, sufficiently concentrated to neutralize all virus, i.e. a serum, the K  value 
of which had been accurately determined. After an additional 7 minutes at 37°C., 0.1  ml. of 
this mixture was added  to 9.9 ml. of nutrient broth  and 0.1  ml. of the dilution was plated, 
using the Phase II organism as host. An appropriate virus assay, and colony count of the cul- 
ture were likewise made. Any back-mutation of the variant 11/3, 4, 7 to the parent Phase II 
organism coukt in this manner be detected and quantitatively assayed. In one or two instances 
it was found that back-mutation to the parent had indeed taken place, but never to an extent 
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greater than 0.3 per cent. These cultures of the II/3, 4, 7 variant were discarded. It was later 
found  that  the  addition  of  MgSO4  apparently  supressed  back-mutation,  for  none  of  the 
batches grown in media containing this substance  showed  the presence of Phase  II bacilli. 
By following the above procedure, several hundred grams of the dried microorganisms, II/3, 
4,  7, were isolated.  Yields of approximately 20 gm.  of dried bacilli per  15  liters of culture 
medium were obtained. 
Isolation of the Purified Somatic Antigen of 11/3, 4, 7.-- 
100 gm. of lyophilized II/3, 4,  7 bacilli was extracted with 0.5  liters of water at pH 7.2 
for 1 hour at 60°C.  The bacteria were separated  by centrifugation, the opalescent aqueous 
extract was filtered through a Berkefeld filter, and dialyzed for 48 hours against  15 liters of 
distilled water.  Seven such extracts were made, and  treated  in this manner.  Each was  con- 
centrated in vaczto to approximately 100 ml. and then dried from the frozen state. The sero- 
logical activity of each extract was determined by turbidimetric titrations against a standard 
antibacterial serum. The absorption spectrum of the material from each extraction was like- 
wise measured. It was found that the third, fourth, and fifth extracts yielded material which 
had  essentially the same absorption  spectra and  serological  activity. The first  two extracts 
were low in activity and were also contaminated with ribonueleic acid; they were discarded. 
The sixth and seventh extracts, though containing no nucleic acid, had only a quarter as much 
substance which precipitated specifically  in antiserum, and were likewise discarded. 
The  material  from  the  third,  fourth,  and  fifth extracts, weighing approximately 9 gm., 
was combined, suspended in distilled water, and adjusted cautiously to pH 8.4 with normal 
sodium hydroxide. After stirring for an hour, the insoluble  residue was removed by centrifuga- 
tion, and  the pH of the supernatant  liquid, which was opalescent but free from particulate 
matter, was adjusted to pH 4.5. A heavy precipitate formed and was centrifuged off, and the 
supernate, which was serologically inert, was discarded. 
The precipitated antigen was again suspended in several hundred  ml. of water and again 
brought to pH 8.4. Recentrifugation at 15,000 g for 30 minutes separated a small amount of 
insoluble material which was discarded.  The active material was again precipitated  at pH 
4.5,  centrifuged, then redissolved at pH 8.4, and the solution finally adjusted to pH 7.2 and 
dialyzed. The antigen was now dried from the frozen state. 6 gm. of material was recovered. 
The  substance  isolated  in  the above manner  is a  phosphorylated  lipomuco- 
protein which contains  11  per cent of nitrogen and  1.0 per cent of phosphorus. 
Its  lipid  and  reducing  sugar  contents  are  10.7  and  6.4  per  cent  respectively, 
when determined  after hydrolysis for 6  hours  at  100°C.  in  1 normal  HC1.  The 
antigen  gives the usual  color reactions  for protein,  and  a  positive Molisch  re- 
action,  indicating  the  presence  of  carbohydrate.  Further  isoelectric precipita- 
tions  failed  to  enhance  the  serological  activity  of  the  antigen,  nor  did  they 
alter  materially  its  chemical  composition.  The  antigen  appears  to  be  hetero- 
dispersed  for on centrifugation  at  15,000  g  a  small amount  of material  is sedi- 
mented  and  separates  as  an  opalescent  jelly.  Neither  the  chemical properties 
nor  the biological activity of the  sedimented  material  shows any  great  differ- 
ences from  those  of the  major portion  of the  substance  in  the  supernatant. 
Enzymatic  Degradation of the PurSUed A ntigen.--The  serological  activity of 
the  antigen  prepared  in  the  above  manner  can  be  considerably  enhanced  by 
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8 gm. of the antigen was dissolved in 300 ml. of 0.02 M phosphate buffer at pH 8.0;  to this 
was added 0.5 gm. of pancreatin which had previously been dissolved in water and centrifuged 
to remove insoluble residue.  The mixture was placed in a cellophane bag together with a few 
milliliters of chloroform, and this in turn has placed in a cylinder of the same buffer saturated 
with toluene. The mixture was incubated for 3 days at 37°C.,  the buffer being changed each 
day.  The material in the membrane was  then  dialyzed thoroughly against  distilled water, 
and the substance isolated by drying from the frozen state. 4.7 gm. was recovered. The ma- 
terial gave both a biuret reaction and a positive Molisch test. The serological  activity of this 
material was nearly four times that of the undegraded antigen. 
The  enzymatically degraded  antigen was  further  fractionated  by  dissolving 2.8  gm.  in 
100 ml. of 0.01 ~ sodium acetate, cooling to 0°C., and adding 100 ml. of acetone. After standing 
for 3 days at -  10°C. the precipitated material was centrifuged off at 0°C., dissolved in water, 
dialyzed, and then frozen and dried. This yielded 2.3 gm. of the purified, enzymatically de- 
graded antigen. The relatively inert material in the supernate, which showed marked absorp- 
tion in the ultraviolet, was discarded. 
II 
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Fro.  2.  Electrophoretic patterns  of the  enzymatically degraded  antigen  of Phase  II/3, 
4, 7 Sh. sonnei. I, pattern  at pH 8.6;  II, pattern  at pH 6.1. 
The  enzymatically  degraded  antigen  is  a  water-soluble  amorphous  powder 
containing  6.3  per  cent  nitrogen  and  2.0  per  cent  phosphorus.  The  specific 
optical  rotation  of  this  materiel  is  low,  [c~]D =  -t-3.4 °.  On  electrophoresis  it 
shows a  considerable degree of homogeneity and migrates as a  single boundary 
(Fig.  2).  The  mobility  of  u  =  -9.86  X  10  .5  cm. 2 volt  -1  sec.  -1,  was  deter- 
mined  at  pH  8.6  in  veronal buffer  of  ionic  strength  0.1;  the  mobility,  u  = 
--11.23  X  10  .5  cm.  2  volt  -t  sec.  -t,  at  pH  6.1  in  phosphate  buffer  of  ionic 
strength  of 0.1,  was  likewise  determined.  The  degraded  antigen  liberated  42 
per  cent  of  lipids  on  hydrolysis  in  1  N  HC1  and  10.7  per  cent  of  reducing 
sugars,  calculated  as  glucose.  The  serological and  antiviral  properties  of this 
substance  will be  discussed  later. 
Isolation of the Lipocarbohydrate.--When  the enzymatically degraded antigen 
is treated with phenol it dissociates into its protein and lipocarbohydrate  com- 
ponents. 
393 mg. of degraded antigen was suspended in 20 ml. of 88 per cent phenol and stirred for 
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dialyzed against successive changes of distilled water for 3 days at 5°C. After removal of the 
phenol there could be seen  within the bag three distinct substances,  a protein conglomerate 
or cake, a  small amount of a  finely divided precipitate,  and  of course the aqueous solution 
containing the lipocarbohydrate. The cake was separated from the finely divided precipitate 
by filtration through a layer of kleenex tissue.  The finely divided precipitate was in turn sepa- 
rated from the solution by high speed centrifugation. The latter was again dialyzed, pervapo- 
rated,  and  dried from the frozen state. This material still contained a small amount of free 
lipid which was removed by extraction with ether.  185 mg.  of substance was recovered. 
The finely divided precipitate, obtained by centrifugation, was dissolved in 5 ml. of water 
by the addition of 0.1 N sodium hydroxide, dialyzed and likewise frozen and dried. 47 mg. was 
recovered. This substance  contained  1.8 per cent nitrogen and  2.7 per cent phosphorus;  its 
nature has not yet been ascertained. 
The  protein cake was  dissolved by adjusting the pH  of a  suspension  to  8.4  with dilute 
NaOH.  The substance was reprecipitated at pH 4,  redissolved and  finally dialyzed, frozen, 
and dried. 120 mg. of material containing 13.5 per cent nitrogen and 0.64 per cent phosphorus 
was obtained. This component had  but slight serological  and antiviral activity and was not 
further investigated. 
Chemical Properties of the Lipocarbohydrate.--The  lipocarbohydrate  isolated 
from the aqueous phase was readily soluble in water, it was serologically active, 
and  could be precipitated  from  solution  by  the addition  of hydrochloric  acid. 
The  complex  contained  2.0  per  cent  nitrogen  and  2.4  per  cent  phosphorus 
and  its  specific optical  rotation  was  [~]~  4°  =  -t-21.2 °. The lipid content  of the 
substance  proved  to  be  higher  than  that  of  the  degraded  antigen;  on  acid 
hydrolysis  some 51  per cent of lipid was liberated  and  the reducing sugar con- 
tent,  10.0 per cent calculated  as glucose, proved to be slightly lower than  that 
of the degraded  antigen.  This fact indicates  that  some hydrolysis  of the poly- 
saccharide  moiety of the antigen  had  taken  place during  treatment  with  con- 
centrated  phenol.  Color  reactions  performed  on  solutions  of  the lipocarbohy- 
drate  revealed  no  pentoses,  desoxypentoses,  uronic  acids,  or  ketohexoses.  A 
determination  of  the  hexose  content  of  the  lipocarbohydrate,  performed  on 
unhydrolyzed  samples  by  the  micro method  of Dische  (10),  revealed that  the 
material  contained  only  traces  of  these  sugars.  The  hexosamine  content  was 
also  determined  (7)  and  found  to be  7.7 per  cent after  10 hours  hydrolysis  in 
4  N HC1,  calculated as glucosamine. 
In  an  attempt  to  identify  the  hexosamine  component  of  the  lipocarbohy- 
drate,  a  hydrolyzed  sample  was  analyzed  on  a  paper  chromatogram  as  pre- 
viously described  (1). 
14.3 rag.  of lipocarbohydrate was hydrolyzed in 5 ml. of 1 N H2SO4 for  10 hours.  After 
removal of the liberated lipid by filtration, the hydrolysate was neutralized with barium hy- 
droxide  to  pH  5.0  and  the  BaSO4  was  separated  by  centrifugation.  The  supernatant  was 
evaporated to dryness.  1.0 rag.  of the residue was dissolved in 10 #1. of water and placed on 
the chromatogram.  Samples of glucosamine and chondrosamine (50 #g.) were likewise placed 
on  the  paper.  The  chromatogram  was  developed  for  24  hours  in  ethyl  acetate-pyridine- 
water mixture (5:3.5:1.5),  then dried, and  stained with ammoniacal silver nitrate. 
From  Fig.  3  it  can be seen  that  the lipocarbohydrate  contains  but  one sac- 
charide,  for only one spot was  observed  on the  chromatogram  developed with 432  PHAGE-RESISTANT  VARIANT  OF  PHASE  II  SHIGELLA  SONNEI 
silver nitrate.  Since this same spot became pink when the chromatogram was 
sprayed with the Elsen-Morgan  (11)  reagent,  it is evident that  the unknown 
saccharide is a  hexosamine. It should be observed, however, that the location 
of  the  spot  formed by  the  unknown  sugar  is  neither  identical  with  that  of 
glucosamine  nor  with  that  of  chondrosamine.  This  fact  indicates  that  the 
hexosamine of the lipocarbohydrate is different from either of these two known 
amino  sugars.  Although  the  exact chemical nature  of  the  hexosamine of  the 
lipocarbohydrate has not yet been determined, the results of  these experiments 
FIO.  3.  Chromatogram of  acid hydrolysate  of  lipocarbohydrate  derived from  variant 
antigen. 
TABLE  I 
Agglutination  Reactions of Phase II Sh. sonnei and  of the Phage-Reslstant  Variant 11/3,  4, 7 
in Antibacterial Immune Sera 
Serum of rabbit 
immunized with 
II bacilli 
II/3, 4, 7 bacilli 
I Microorganism ! 
tested 
II 
1I/3, 4, 7 
II  +++ 
II/3, 4, 7  +++ 
Final dilution of antiserum 
1:100  1:200  1:400  1:800  1:1600  1:3200 
++++++++  ++~  ++  0  0 
+++++++++++++++  +  0 
indicate  clearly that  the  chemical  composition  of the  antigen  of the variant 
bacillus differs radically from that of the parent Phase II organism. 
Agglutination Reactions of Phase II Sh.  sonnei and Its Phage-Resislant  Variant, 
11/3,  4,  7,  in Antibacterial  Immune  Sera.--In  order to learn something of the 
serological  relationship  of  these  two  microorganisms,  extensive  studies  were 
carried out on the agglutination reactions of Phase II Sh.  sonnei and its vari- 
ant,  II/3, 4,  7.  Since  the  specificity of these  reactions  is  determined  by the 
lipomucoprotein distributed on the cell  surface of each, any differences which 
they  might  show,  in  so  far  as  their  immunological  reactions  are  concerned, 
must be related to differences in this antigenic component. The sera of rabbits 
which had been immunized with Phase II Sh. sonnei will,  of course, agglutinate 
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was tested  in these same sera,  however, it  can be seen from Table I  that no 
detectable  agglutination occurred. 
The cultures of the two microorganisms tested were grown with aeration in casamino acid- 
meat extract  medium until  the bacterial population  had reached approximately  2.5  X  l0  s 
cells per ml. In all cases the sera to be tested were diluted in nutrient  broth medium. The 
variant microorganism, II/3, 4, 7, has a tendency to aggregate as the culture ages, or as it 
stands. Since it also tends to aggregate when diluted in physiological salt solution, it was neces- 
sary to use young cultures, to carry out the serum dilutions in broth, and to read the agglu- 
tination  reactions after 2 hours incubation at 37°C. 
The results presented in the first half of Table I appear to have but one inter- 
pretation;  namely,  that  the antigen  distributed  on the  surface of the parent 
cell differs from that on the cell surface of the variant, and that this difference 
is sharply reflected in the immune response elicited in animals immunized with 
the  Phase  II organism.  If one  now  examines  the  agglutination  reactions  of 
TABLE II 
Agglutination Reactions of Phase II Sh. sonnei and of the Phage-Resistant Variani 11/3, 4, 7 
in Anti-Antigen Immune Sera 
Serum of rabbit 
immunized with 
[I antigen 
II/3, 4, 7 antigen 
Microorganism 
tested 
II 
II/3, 4, 7 
II 
II/3, 4, 7 
1:50 
+++ 
0 
+++ 
++++ 
Final dilution of antiserum 
1:100  1:200  1:400 
+++  +++  ++ 
0  0  0 
+++  +++  ++ 
+++++++++++ 
1:800 
+ 
0 
+ 
++ 
1:1600  1: 320C 
4-  0 
0  0 
0  0 
+  4- 
these two bacilli in the sera of animals immunized with the variant II/3, 4, 7 
(Table I), it is seen that both microorganisms are agglutinated. The significance 
of these observations, which at first sight appear to be paradoxical, will be dis- 
cussed later. 
Agglutination Reactions of Phase H  Sh. sonnei and the Phage-Resistant Vari- 
ant,  II/3,  4,  7,  in Somatic Antigen Antisera.--Because  the  somatic antigens 
of the two microorganisms under consideration were obtained in a highly puri- 
fied form, it was possible to investigate the specificity of the antibodies which 
each elicits in experimental animals. These antisera are presumably monovalent 
and  contain antibodies  directed  against only the two somatic antigens  them- 
selves. We have at hand two such sera, one from animals immunized with the 
Phase  II  antigen,  the  other  from  rabbits  injected  with  the  antigen  of  the 
variant II/3, 4, 7. 
In Table II are presented  the results  of the agglutination  of the Phase II 
organism,  and  of the phage-resistant  variant,  II/3, 4,  7,  in Phase II antigen 
antiserum. Here it can be seen that the agglutination reactions follow a pattern 434  PHAGE-RESISTANT  VARIANT  OF  PHASE  II  SHIGELLA  SONNEI 
identical with that shown by the corresponding Phase II antibacterial serum. 
The mutant cell is not agglutinated by the antiserum elicited by the Phase II 
antigen.  When  similar  tests  are  made  using  the  sera  of rabbits  immunized 
with the enzymatically degraded antigen derived from the mutant cell,  II/3, 
4, 7, it can be seen that these sera also agglutinate the homologous microor- 
ganism, and show crossing with the heterologous Phase II cell. Again the pat- 
tern shown by the antibacterial sera is duplicated. In this instance, however, 
it should be pointed out that the cross-agglutination of the Phase II organism 
TABLE III 
Precipitin Reactions of the Somatic Antigens of Pha~e II Sh. sonnei and of the Phage-Resistant 
Variant 11/3, 4, 7 in Antibacterial Immune Sera 
Serum of rabbit 
immunized with 
II bacilli 
II/3, 4, 7 bacilli 
Somatic antigen 
tested 
II 
11/3, 4, 7 
II 
II/3, 4, 7 
Final dilution of antigen 
, 5o 1,,25o o 
+ i  o  o 
+  I  ++~=  I  ++  [  ~=  o 
/  +++  I+++1  +  ± 
TABLE IV 
Precipitin  Reactions of the Somatic Antigens of Pkase II Sh. sonnei and of the Phage-Resistant 
Variant 11/3, 4, 7 in Anti-Antigen Immune Sera 
Serum of rabbit 
irnmunized wlth 
II antigen 
II/3, 4, 7 antigen 
Somatic antigen 
tested 
II 
II/3, 4, 7 
II 
11/3, 4, 7 
1:2:000 
++± 
0 
++ 
++++ 
Final dilution of antigen 
1:10:000  1:50,000  1:250,000  [1:1,250,000 
++++1  +++1  +  I  +  ol0t010 
+++  +±  q-  0 
++++l  ++1  +  I  + 
in anti-antigen immune serum does not appear to be as vigorous as in the cor- 
responding antibacterial sera. 
Precipitin Reactions.--The  precipitin reactions of the two purified antigens 
derived from the Phase II bacillus and from the variant II/3, 4, 7 were next 
investigated. These results are presented in Tables III and IV. It can be seen 
that the specificity of these reactions parallels those shown by the agglutination 
reactions of the two microorganisms. The antibodies elicited by the Phase II 
bacillus, and by its purified somatic antigen, show a high degree of specificity. 
These antisera precipitate only the antigen of the parent Phase II bacillus and 
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bits  injected  with living II/3, 4,  7  bacilli,  or with  the purified  antigen,  give 
rise to immune bodies which precipitate the homologous II/3, 4, 7 antigen, as 
one would of course expect. Yet these  same sera,  unlike  those evoked by the 
parent cell or its somatic antigen,  readily cross-react. 
Antiviral Properties of the 11/3, 4, 7 Antigen.--Phase  II Sh. sonnei is suscep- 
tible  to lysis by five of the T  series of coil-dysentery  phages,  T2 and To, and 
T3, T4, and TT, whereas the variant,  II/3, 4, 7, is attacked only by T, and To. 
TABLE V 
Inhibition of T Pheges by the Antigen of Sh. sonnei H/3, 4, 7 
Substance tested 
Purified antigen 
Purified antigen 
after enzymatic 
degradation 
Final concentration of antigen in virus-antlgen 
Plating  mixture" 
microorganL~m 
1.0 rag.  0.1 nag.  0.01  rag.  0.001  mg.  0.0001  rag, 
II/3, 4, 7  T,  74  51  47 
Te  12  0  0 
i 
T,  86  74  57 
T6  0  0  0 
Phase II  T3  0  0  0 
T,  0  0  0 
"1"7  0  0  0 
2"2  100  100  100  96  77 
II/3, 4, 7  T6  0  0  0 
T,  100  99  100  98  80 
Te  0  0  0 
Phase II  Ta  0  0  0 
"1"4  ]  0  0  0 
"1"7  !  49  0  0 
* The figures represent per cent of total phage inactivated. 
As pointed  out in the previous  communication  (1),  the  Phase  II antigen  in- 
activated in vitro all the T phages to which this bacillus is susceptible. 
It has also been seen from the foregoing that the somatic antigens derived 
from the Phase II bacillus and from its variant,  II/3, 4,  7, are endowed with 
distinct and individual serological specificities. It is of great interest,  therefore, 
to  determine  whether  the  somatic  antigen  of the  phage-resistant  variant  is 
capable of inhibiting the T~ and Te viruses to which the II/3, 4, 7 organism is 
susceptible,  and also to ascertain  whether this antigen will inhibit  the phages 
which attack the parent  Phase II bacillus. 
Freshly prepared  stocks of the virus under study were so diluted as to contain 2 X  10  3 
particles per ml. 0.5 ml. of varying concentrations  of the antigen were placed into each of 
four tubes, and to these was added 0.5 ml. of the virus dilution. A fifth tube containing 0.5 436  PHAGE-R-ESISTANT  vARIANT  O]~  PHASE  II  SHIGELLA SONNEI 
ml. of virus and 0.5 ml. of broth served as control. After 18 hours incubation at 37°C.,  0.1 
ml. of each virus-inhibitor mixture was plated, using the Phase II bacillus in one instance, 
and the II/3, 4, 7 variant in the other, as the host. Plaque counts were made after incubation 
at 37°C.  for 18 hours. In the case of the T7 phage, the platings were made on neopeptone- 
meat infusion-agar. The results of these experiments are recorded in Table V. 
The results of the specific inhibition tests presented in Table V reveal cer- 
tain salient facts. First, the antigen derived from the variant microorganism 
is a  powerful antiviral agent, but its activity is confined to the inhibition of 
T~, whether the host be the parent or the variant microorganism. Unlike the 
antigen of the Phase II bacillus,  that of the mutant, either before or after 
enzymatic degradation,  fails to  inhibit Tr--the  only other phage  of  the T 
series  to which the mutant cell is susceptible. Second, the antigen, as well as 
its products of degradation,  is  incapable of inhibiting T3,  T4,  and TT.  This 
observation is quite in accord with the anticipated result, for the variant itself 
is resistant to these three phages and hence its surface antigen, the lipomuco- 
protein, cannot function as a receptor for them. It cannot be said at the pres- 
ent time just why the antigen of the mutant cell is devoid of activity against 
Ts, whereas that of the parent Phase II organism, as was shown in the pre- 
ceding communication, is active against this particular phage.  This may be 
due to the chemical treatment which the antigen receives during its purifica- 
tion. This suggestion has some basis in fact because it was observed that one 
or  two preparations  of the mutant antigen, although it is not indicated in 
Table V, actually showed some activity against Te, though never against Ts, 
T4, or TT. 
In sum it can be stated that the differences in chemical nature of the anti- 
gens of Phase II Sh.  sonnei and its variant, II/3, 4, 7, are reflected not only 
in their diverse serological specificities, but also in dissimilarities in their specific 
antiviral properties as well. 
DISCUSSION 
A population of F.. Co//B is by no means homogeneous but contains a num- 
ber of different mutants, the presence of which can be demonstrated by means 
of a  series of bacteriophages. While Demerec and Fano (12)  were concerned 
with the classification of these variants and the genetic factors involved in 
their differentiation other investigators have studied the relationship between 
phage sensitivity and antigenic structure; it has been repeatedly demonstrated, 
even  among microorganisms otherwise unrelated,  that  a  common suscepti- 
bility to a given phage may be correlated with similarities in antigenic struc- 
ture. The earlier literature in this field, and that dealing with attempts to iso- 
late the socalled phage receptor substances from susceptible  organisms have 
been reviewed in a previous communication (2). In addition, it is well to make 
mention of the important and more recent work of Beumer (13), Weidel (14), 
and that of Mondolfo and Hounie (15). WALTHER  F.  GOEBEL  AND  MARGERIS  A.  JESAITIS  437 
The loss of susceptibility of certain Gram-negative bacilli to phages has also 
been correlated with changes from the smooth to the rough form, and it has 
been pointed  out that  these changes  are frequently,  though  not  always,  ac- 
companied by alteration in their serological specificity (16). In certain instances 
this change has been attributed  to the loss in function of the cell to elaborate 
its type-specific agglutinogen. It should be pointed out, however, that the inter- 
pretation of serological evidence per se is by no means certain,  for it has been 
seen from the foregoing thfft Phase II Sk. sonnei can undergo variation to yield 
a rough form which fails to agglutinate in antisera  evoked by the parent cell. 
On the basis of this  evidence it would appear at first sight  that  the variant 
II/3,  4,  7 has indeed lost the function  of elaborating  a  type-specific antigen, 
yet chemical scrutiny has revealed that this is not the case. It is still endowed 
with enzyme systems capable of synthesizing a lipocarbohydrate protein com- 
plex, though to be sure it is different, both chemically and serologically, from 
that of the parent.  In addition,  this newly constituted complex is incapable of 
inhibiting  in vitro  three of the phages to which the parent  is susceptible. 
The fact that the antisera  elicited in rabbits immunized  with Phase II  Sh. 
sonnei are specific and fail to agglutinate  the variant  II/3,  4,  7, while those 
evoked by the latter  microorganism  cross-react with  the parent  cell,  at first 
appears  paradoxical.  It  was demonstrated  in  these laboratories  many  years 
ago,  however,  that  it  is  possible  for  azoprotein  antigens  containing  disac- 
charides of known chemical structure,  to  evoke in experimental  animals anti- 
bodies which show a non-reciprocal immunological relationship  (17).  It is sug- 
gested  that  the  serological  relationship  between  the  antigen  of  the  parent 
Phase II bacillus and that of the variant  II/3, 4, 7 is likewise governed by the 
chemical configuration of their respective carbohydrate moieties, and that this 
phenomenon  is comparable  to  that  exhibited  by the  azoprotein  antigens  re- 
ferred to. 
In the previous communication  (1)  evidence was presented which left little 
doubt that  the antiviral  properties  of the Phase  II antigen,  in so far as Ts, 
T4,  and  T7 are  concerned,  are a  function  of the  carbohydrate moiety of the 
molecular complex. In the present study it has been shown that the polysac- 
charide  of the  variant  antigen  differs radically  from  that  of the  parent.  In 
view of this it is suggested that,  not only is the serological specificity of each 
antigen  governed by its  carbohydrate  component,  but that  its ability to in- 
hibit the T3, T4, and T¢ phages is likewise determined by this same constituent. 
In  the  one instance,  the  structure  of the  biologically  active  polysaccharide 
appears to be such that it is fully capable of combining with and inactivating 
these phages in vitro.  In the other, failure of the antigen  to interact  with the 
phage must mean that the appropriate geometric pattern of the forces required 
for specific combination is no longer present. 
In  conclusion  it  should  be  emphasized  that  variation,  as  exemplified  by 
Phase II Sk. sonnei and its variant,  II/3,  4, 7, does not necessarily involve a 438  PHAGE-RESISTANT  VARIANT  OF  I~HASE  II  SHIGELLA  SONNEI 
complete loss in ability to synthesize a lipocarbohydrate protein complex, but 
that this function is altered and appears to involve changes in the enzyme sys- 
tem which is responsible for the synthesis of the carbohydrate component of 
the thermostable agglutinogen. 
During the course of this work the authors engaged in a number of stimulat- 
ing conversations with Dr. Theodore Shedlovsky. For his interest and his sug- 
gestions we are deeply grateful. 
SUMMARY 
1.  A  phage-resistant variant of Phase II Shigella sonnei has been isolated 
and the type-specific antigen from it has been obtained. 
2.  The antigen of the variant microorganism, II/3, 4,  7, differs from that 
of the parent Phase II bacillus in serological specificity and in chemical make-up. 
3.  Although the antigen of Phase II Sh. sonnei inhibits all T phages to which 
the bacillus is susceptible, that of the variant fails to inhibit Ta, T4, and TT. 
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